Summarizes the achievements of the pharmaceutical/biotechnology benchmarking program from 2005-2009. Describes the development of the metrics and the benchmarking system that uses them to enable better decision making and continuous improvement in the pharmaceutical/biotechnology industry. Offers data analysis to illustrate the value of the pharmaceutical/biotechnology benchmarking system to capital project delivery in the industry. Also shows how benchmarking helps participants identify performance gaps, determine the best approach to performance improvement, and track performance.
Document identifier
CII BMM2009-10
Title
Pharmaceutical and Biotechnology Facility Benchmarking Summary Report, 2005-2009
CII Category
Performance Assessment
Publication date
2009-12-01
International Relationship
| Price |
120 vnd |
.jpg){kind=logo}
---Logo.jpg){kind=logo}
.jpg){kind=logo}
-_-logo.png){kind=logo}
.jpg){kind=logo}
.png)
